Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Conversion of CD73hiFR4hi anergic T cells to IFN-γ–producing effector cells disrupts established immune tolerance
Anil Dangi, … , Shuangjin Yu, Xunrong Luo
Anil Dangi, … , Shuangjin Yu, Xunrong Luo
Published January 17, 2023
Citation Information: J Clin Invest. 2023;133(5):e163872. https://doi.org/10.1172/JCI163872.
View: Text | PDF
Research Letter Immunology

Conversion of CD73hiFR4hi anergic T cells to IFN-γ–producing effector cells disrupts established immune tolerance

  • Text
  • PDF
Abstract

Authors

Anil Dangi, Irma Husain, Collin Z. Jordan, Shuangjin Yu, Xunrong Luo

×

Figure 1

Conversion of CD73hiFR4hi anergic T cells to IFN-γ–producing cells disrupts established transplantation tolerance.

Options: View larger image (or click on image) Download as PowerPoint
Conversion of CD73hiFR4hi anergic T cells to IFN-γ–producing cells disru...
(A) TAN cells are enriched in islet allografts and spleens of tolerized recipients. n = 6–12 per group. (B) Loss of TAN cells in islet allografts following MCMV infection of stably tolerized recipients. n = 3–9 per group. (C) TAN cells from tolerized recipients are induced to produce IFN-γ by MCMV-infected DCs (representative of 2 independent experiments). (D) In vivo conversion of adoptively transferred CD45.2 TAN cells following MCMV infection of CD45.1 hosts. n = 2–3 per group. (E) Depletion of TAN cells prevents MCMV-mediated transplant tolerance disruption. n = 3–5 per group. (F) Experimental scheme in RAG–/– mice. (G) In vivo conversion of adoptively transferred TAN cells following MCMV infection of RAG–/– (representative of n = 4). (H) Rejection of islet allografts in RAG–/– following TAN adoptive transfer. n = 3–4 per group. *P < 0.05. (A–D) Mann-Whitney test. (E) Log-rank test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts